AzTrials
AzTrials

Diastasis RectiDRANCT05709704

Comparison of Overall Function Between Postpartum Women With and Without Diastasis Rectus Abdominis

An observational study of Diastasis Recti, run by Texas Woman's University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to examine the effects of diastasis rectus abdominis on the overall function of postpartum women and to determine test-retest reliability and construct validity of a self-assessment palpation of inter-rectus distance for DRA using telehealth. Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Diastasis Recti
What is being tested?
Self-palpation via telehealth and Real-time Ultrasound
How many people
150 participants
Where
1 siteUnited States
Study dates
2 Jul 2021to May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter. An announcement will also be included in the Wichita State University Shocker Blast and Strategic Communications. The recruitment fliers will ask interested women to email a research assistant to enroll in the research project.

Who may be able to join

  • Women ages 18-40 years
  • Postpartum (within 6-10 weeks of vaginal delivery)

Who cannot join

  • Women who are currently being treated by a physical therapist for their diastasis rectus abdominis
  • Women who had high-risk pregnancies (bedrest, gestational diabetes, pregnancy-induced hypertension)
  • Women with a history of abdominal or back surgery
  • Women with history of connective tissue disease such as Ehlers-Danlos Syndrome

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Wichita State University

    Wichita, Kansas, 67260

    Jennifer Celso, DPT, 316-978-5648, jennifer.celso@wichita.edu

    Jennifer Celso, DPT

    Recruiting

Other trials in United States

About this study

The purpose of this research is to examine the effects of diastasis rectus abdominis on the overall function of postpartum women and to determine test-retest reliability and construct validity of a self-assessment palpation of inter-rectus distance for DRA using telehealth.

Read the detailed description

Step 1: Recruitment

  • The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter.
  • The recruitment fliers will ask interested women to email a student investigator to enroll in the research project.

Step 2: Collection of functional outcome data using a Qualtrics version of the Inventory of Functional Status After Childbirth (IFSAC), a demographic survey, a numeric pain reporting scale, Oswestry Low Back Pain Disability Questionnaire, and the Pelvic Floor Distress Index.

Step 3: A meeting time will be set up with every participant to conduct a telehealth visit with a research assistant. During this virtual visit on a private, password protected Zoom call the participant will be instructed on self-assessment palpation of the abdominal wall in order to determine the presence or absence of diastasis rectus abdominis (DRA) along the inter-rectus distance (IRD).

Step 4: The first 18 participants with self-assessed DRA and the first 18 participants without self-assessed DRA, who live in Wichita or surrounding areas, will be scheduled for a one-time in-person confirmation appointment. The appointment will last a maximum of 15 minutes and occur at the WSU Old Town campus room A106. During this confirmation appointment research assistants will screen the participant with the COVID Pre-screening Questions Tool, obtain written informed consent, check the participant in, collect height and weight, and the principal investigator will measure the participants abdominal wall using real-time ultrasound, measure the IRD using the PI's palpation method, and ask the participant to demonstrate and measure IRD using the same palpation method used on the telehealth visit. See the virus protection plan for details of which all participants and investigators will follow in order to minimize risks related to COVID-19).

Step 5: The data will be entered into SPSS and analyzed with appropriate statistical analyses.

Conditions
Diastasis Recti
Being tested
Self-palpation via telehealth, Real-time Ultrasound
Keywords
Overall Function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-palpation via telehealthDiagnostic test

    This will be used to determine if the participant has the diagnosis

  • Real-time UltrasoundDiagnostic test

    This will be used in a subgroup of participants to confirm/rule out a diagnosis

Study groups in NCT05709704
Study groupRoleWhat they receive
Postpartum Women WITH DRAParticipants who have the diagnosis of diastasis rectus abdominis
Receives: Diagnostic Test: Self-palpation via telehealth; Diagnostic Test: Real-time Ultrasound
Postpartum Women WITHOUT DRAParticipants who do not have a diagnosis of diastasis rectus abdominis
Receives: Diagnostic Test: Self-palpation via telehealth; Diagnostic Test: Real-time Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inventory of Functional Status after Childbirth

    Questionnaire used to measure a postpartum woman's ability to function within 5 different domains.

    Measured: one time between 6-10 weeks postpartum

Secondary outcomes (3)
  1. Numeric Pain Scale

    0-10 scale for the participant to identify any areas of pain in various regions of the body

    Measured: one time between 6-10 weeks postpartum

  2. Oswestry Low Back Pain Disability Index

    A questionnaire to determine if the participant has any disability in the presence of low back pain

    Measured: one time between 6-10 weeks postpartum

  3. Pelvic Floor Distress Index

    Questionnaire to determine if the participant has pelvic floor dysfunction

    Measured: one time between 6-10 weeks postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2023
  2. Study start2 Jul 2021
  3. Primary completionMay 2023 (estimated)
  4. Study completionMay 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05709704
Sponsor's protocol ID
IRB-FY2021-405
Acronym
DRA
Status last verified
Jan 2023
First submitted
7 Jul 2022
Last updated
2 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Diastasis Recti, run by Texas Woman's University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inventory of Functional Status after Childbirth (time frame: one time between 6-10 weeks postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in